Tuğba Aydoğan Gezginaslan

8PUBLICATIONS
22CO-AUTHORS
Optical technologyVision scienceTe hauora me te oranga ā-whaea, ā-pēpi o te Māori (Māori mothers and babies health and wellbeing)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 22, 2026
Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema.

|Jul 16, 2026
Sequential Cilioretinal Artery Occlusion and Acute Anterior Uveitis as the Initial Ocular and Systemic Manifestation of Systemic Lupus Erythematosus: A Case Report.

|Jul 15, 2025
Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5.

Tuğba Aydoğan Gezginaslan, Abdullah Özkaya, Mehmet Orkun Sevik

|Sep 24, 2024
Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10.

Erdinç Bozkurt, Fatih Bilgehan Kaplan, Ecem Önder Tokuç

|Sep 05, 2024
Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group.

Ecem Önder Tokuç, V Levent Karabaş, Mehmet Orkun Sevik

|Aug 01, 2024
One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13.

Dr Utku Limon, Fatih Bilgehan Kaplan, Işılay Saygın

Pageof 2

Frequent Collaborators

7 joint publications

Utku Limon

7 joint publications

Erdinç Bozkurt

6 joint publications

Mehmet Orkun Sevik

5 joint publications

Işılay Saygın